2030 Positron emission tomography in patients with head and neck carcinoma
β Scribed by Christopher U. Jones; Peter E. Valk; Ernest E. Johnson; Thomas R. Pounds
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 92 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background A single institution study was undertaken to evaluate the role of positron emission tomography (PET) scans with fluorodeoxyglucose (FDG) prior to radiation and following radiation. ## Methods Fortyβfive patients with head and neck cancers were evaluated with FDGβPET sca
## Abstract ## __Background__. We assessed the role of ^18^Fβfluoroβdeoxyβglucose positron emission tomography (PET) in detecting head and neck squamous cell carcinoma (HNSCC) after definitive chemoradiotherapy (CRT). ## __Methods__. A prospective study presented 80 PET before and after CRT for
## Abstract __Background__. Positron emission tomography (PET) provides a noninvasive modality for evaluating the biochemical processes of normal and pathologic tissue. Preliminary reports of Fβ18 fluorodeoxyglucose (FDG) PET indicate its potential usefulness in evaluating head and neck tumors. The
## Background: [f-18]fluorodeoxyglucose (fdg)-positron emission tomography (pet) can measure the metabolic activity of tissues; fdg-pet may be able to predict response to chemotherapy by identifying changes in tumor metabolism. measurement of response to treatment may help improve survival in the m
## Abstract ## Background The aim of this study was to evaluate the accuracy of positron emission tomography (PET) in assessing the patients treated with primary chemoradiotherapy for mucosal carcinoma of the head and neck. ## Methods A retrospective review of patients with biopsyβproven cancer